ClinicalTrials.gov
public full text
Public Domain
An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
The purpose of this protocol is to allow subjects who completed any BHV3000 (rimegepant) clinical study to continue to have access to rimegepant while collecting ongoing safety data. (NOTE: ONLY FOR PATIENTS who participated in a previous BHV-3000/Rimegepant Clinical Trial in the past)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults#892351
- Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine#1093040
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment#1150357
- The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras#896633
- Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo#1138124
Record · ID 1152039
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive